返回 Agenda
Session 2: How RBM Binds all Stakeholders - Data Managers, Statisticians, Monitors, Investigators and Inspectors
Session Chair(s)
Mette Mackeprang Bruhn, MA
Team Leader
Novo Nordisk A/S, Denmark
How RBM Binds all Stakeholders - Data Managers, Statisticians, Monitors, Investigators and Inspectors
Speaker(s)
The Evolving Role of the Clinical Data Manager in the Times of Risk-based Monitoring
Johann Proeve, PHD
Cyntegrity, Germany
Chief Scientific Officer
Risk-Based Monitoring – Perspective from a Statistician
Nicola Schmitt
AstraZeneca, United Kingdom
Global Product Statistician
Big Data' Analytic Methods to Simplify Risk-Based-Monitoring and Fraud Detection in Clinical Trials
Hartmut Schmied
Biorasi, Germany
Vice President, Head of European Operations
Using Powerful and Pragmatic Central Statistical analytics to Drive Quality into Clinical Trials
Erik Doffagne, MS
CluePoints, Belgium
Product Manager